CLINICAL CASE

CLINICAL CASE

CLINICAL CASE

CLINICAL CHALLENGE:

  • Insufficient alveolar ridge height for implant placement and proximity to the alveolar nerve
  • Autologous bone harvesting is associated with patient discomfort

AIM/APPROACH:

  • Interpositional grafting with Geistlich Bio-Oss® Block for vertical augmentation
  • Alveolar ridge volume preservation and minimizing patient morbidity

CLINICAL CASE

CLINICAL CHALLENGE:

  • Severely atrophied alveolar ridge with insufficient bone volume for implant placement
  • ­­­­High complication rates and patient discomfort associated with large augmentations when using autologous bone grafts

AIM/APPROACH:

  • 3-dimensional augmentation of alveolar ridge by the fence technique for implant placement
  • At the same time reducing complication rates and patient discomfort

CLINICAL CASE

CLINICAL CHALLENGE:

  • Insufficient alveolar ridge width for implant placement
  • Autologous bone is subject to resorption and may lead to loss of volume

AIM/APPROACH:

  • Ridge Split procedure in combination with Geistlich Bio-Oss® and Geistlich Bio-Gide® for horizontal augmentation
  • Preservation of the alveolar ridge volume

CLINICAL CASE

CLINICAL CHALLENGE:

  • Insufficient alveolar ridge width for implant placement
  • Donor site morbidity after autologous bone block harvesting and resorption of autologous bone

AIM/APPROACH:

  • Horizontal alveolar ridge augmentation with Geistlich Bio-Oss® and Geistlich Bio-Gide®
  • Minimizing autologous bone harvesting and resorption protection

CLINICAL CASE

CLINICAL CASE

CLINICAL CASE

CLINICAL CASE

CLINICAL CASE

CLINICAL CASE

CLINICAL CASE

CLINICAL CASE

CLINICAL CASE

CLINICAL CASE

CLINICAL CASE

CLINICAL CASE

CONCLUSIONS:

  • Geistlich Mucograft® with a keratinized tissue strip was utilized to increase vestibular depth and gain additional keratinized tissue.
  • Augmentation of severely atrophied alveolar ridge provided sufficient bone for implant placement 8 months following augmentation.

CLINICAL CASE

CLINICAL CASE

CLINICAL CASE

CLINICAL CASE

CLINICAL CASE

VIDEO

Introducing the first xenogenic / allogenic validated bone substitute1